age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66.50195
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 9,212
| null | null | 11
|
white
| 19.199219
| 20
| 0.658936
| 0.35498
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 88
| 9.599609
| 68
| 24
| 37.69531
| null | null | null | 1.5
| 142
| null | 97
| 15
| null | null | null | null | 2.089356
| 380
| 1
|
58.55399
|
male
| 0
| 40
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$25-$50k
| 9
| 59,511
| null | null | 20.5
|
white
| 26.296875
| 43
| 0.782959
| 0.652954
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 40
| 132
| 11.798828
| 125
| 28
| 35.29688
| null | 2.199707
| 0.199982
| 3.399902
| 129
| null | 237
| 38
| null | null | 0
| null | 0
| 408
| 0
|
56.879
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 26
| 28,747
| null | null | 14.333328
|
black
| 25.5
| 59
| 0.709961
| 0.622925
| 3
| 1
| 0
|
no
| null | null |
no dnr
| 19
| 65
| 13.199219
| 40
| 28
| 36
| 230
| 2.099609
| 0.899902
| 0.799927
| 147
| 7.509766
| 292
| 25
| 3,685
| null | 1
|
<2 mo. follow-up
| 1
| 26
| 1
|
68.70398
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 41
| 67,965
| null | null | 27
|
white
| 34.195313
| 32
| 0.228973
| 0.129974
| 5
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 20
| 135
| 13.798828
| 115
| 40
| 36.79688
| 225
| null | null | 1
| 143
| 7.399414
| 154
| 17
| 4,350
| null | 0
|
no(M2 and SIP pres)
| 0
| 407
| 0
|
62.52698
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
|
under $11k
| 9
| 47,565
| null | null | 15.5
|
black
| 17.796875
| 27
| 0.826904
| 0.767944
| 13
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 11
| 128
| 23.296875
| 125
| 12
| 36.5
| 100
| 4
| null | 1.299805
| 132
| 7.419922
| 201
| 49
| 2,865
| null | 0
|
<2 mo. follow-up
| 0
| 36
| 1
|
38.116
|
male
| 0
| 33
|
Coma
|
Coma
| 0
| null |
$11-$25k
| 44
| 75,735
| null | null | 31.25
|
hispanic
| 19
| 29
| 0.803955
| 0.765991
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 33
| 82
| 5.5
| 115
| 3
| 38.79688
| 255
| 2.699707
| 3.899902
| 0.799927
| 150
| 7.459961
| 98
| 10
| 4,680
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 407
| 0
|
55.60599
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 19,455
| null | null | 16
|
white
| 18
| 34
| 0.820923
| 0.613892
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 80
| 20.597656
| 88
| 24
| 36.39844
| null | 3.699707
| 0.599976
| 0.699951
| 135
| null | 86
| 5
| null | 1
| null | null | 1.166748
| 406
| 0
|
32.75598
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 21,960
| null | null | 19.5
|
hispanic
| 21.199219
| 28
| 0.81897
| 0.609985
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.65
|
no dnr
| 10
| 77
| 10.798828
| 80
| 16
| 38.09375
| null | 4.5
| 0.699951
| 0.799927
| 145
| null | 88
| 12
| 7,275
| 0
| 6
|
no(M2 and SIP pres)
| 6
| 406
| 0
|
58.51599
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 16
|
>$50k
| 37
| 11,001
| null | null | 12.5
|
white
| 33
| 46
| 0.131989
| 0.007
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 3
| 118
| 5.599609
| 115
| 24
| 35.59375
| 120.40625
| 3
| 0.5
| 0.799927
| 135
| 7.419922
| 91
| 10
| 2,020
| null | 6
|
<2 mo. follow-up
| 6
| 12
| 1
|
61.89999
|
male
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
|
>$50k
| 0
| 154,913
| null | null | 31.25
|
white
| 22.597656
| 34
| 0.802979
| 0.737915
| 5
| 0
| 0
|
no
| 0.98
| 0.97
|
no dnr
| 46
| 102
| 7.099609
| 55
| 8
| 36.59375
| 205
| 2.199707
| 4.299805
| 0.599976
| 138
| 7.339844
| 246
| 19
| 1,090
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 405
| 0
|
30.467
|
male
| 0
| 123
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 320,730
| null | null | 14.25
|
white
| 15.199219
| 19
| 0.953979
| 0.920898
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 123
| 108
| 15.898438
| 110
| 22
| 36.79688
| 324
| 2.299805
| 1.299805
| 1.199951
| 140
| 7.40918
| 98
| 33
| 2,060
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 405
| 0
|
55.806
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 2
|
under $11k
| 0
| 15,359
| null | null | 14
|
black
| 21.199219
| 30
| 0.866943
| 0.819946
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 73
| 5.199219
| 170
| 26
| 36.29688
| null | null | 2.599609
| 1.099854
| 140
| null | 95
| 15
| 2,160
| 1
| 2
|
no(M2 and SIP pres)
| 2
| 404
| 0
|
39.28799
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 37
| 67,588
| null | null | 23
|
black
| 38.5
| 67
| 0.392944
| 0.274963
| 8
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 108
| 14.099609
| 115
| 8
| 38.09375
| 160
| 2.399902
| 1.399902
| 8.699219
| 139
| 7.40918
| 216
| 96
| 215
| null | null |
<2 mo. follow-up
| 2.919434
| 4
| 1
|
76.82397
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 130,680
| null | null | 23
|
white
| 27.296875
| 39
| 0.60791
| 0.500977
| 21
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 29
| 72
| 16.699219
| 65
| 10
| 37.5
| 120
| null | 0.899902
| 1.299805
| 139
| 7.479492
| 151
| 27
| 940
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 404
| 0
|
68.75598
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 9,662
| null | null | 8
|
white
| 10.298828
| 10
| 0.884888
| 0.738892
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 7
| 95
| 11.599609
| 55
| 29
| 35.69531
| 108.32812
| 2.5
| 2.299805
| 2.899902
| 123
| 7.349609
| 109
| 72
| 1,290
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 404
| 0
|
70.66095
|
male
| 0
| 37
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
| null | 44
| 70,272
| null | null | 18.75
|
white
| 22.699219
| 38
| 0.533936
| 0.418945
| 1
| 0
| 0
|
yes
| 0.1
| 0.1
|
dnr after sadm
| 2
| 122
| 19.097656
| 135
| 10
| 35.89844
| 247.5
| 5.099609
| 5.099609
| 5.899414
| 148
| 7.389648
| 243
| 51
| 140
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 404
| 0
|
37.76898
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 0
| 19,026
| null | null | 17
|
white
| 24.5
| 57
| 0.876953
| 0.832886
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 107
| 9.898438
| 80
| 20
| 36
| null | 2.899902
| 0.599976
| 3.899902
| 132
| null | 73
| 56
| 4,025
| 6
| null |
no(M2 and SIP pres)
| 4.527344
| 403
| 0
|
22.905
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 79,249
| null | null | 26.333328
|
white
| 34.796875
| 69
| 0.747925
| 0.667969
| 7
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 20
| 135
| 37.695313
| 135
| 10
| 38.89844
| 135.53125
| 2
| 1.299805
| 1.199951
| 134
| 7.429688
| 164
| 9
| 4,413
| null | 0
|
no(M2 and SIP pres)
| 0
| 403
| 0
|
72.73395
|
female
| 0
| 70
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
under $11k
| 26
| 186,634
| null | null | 31.5
|
black
| 18.699219
| 40
| 0.780884
| 0.648926
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 70
| 122
| 24.597656
| 100
| 30
| 35.19531
| 436.625
| null | 0.599976
| 1.199951
| 144
| 7.369141
| 261
| 22
| 3,005
| null | 0
|
SIP>=30
| 0
| 140
| 1
|
72.80194
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 9
| 193,359
| null | null | 34.75
|
white
| 27
| 58
| 0.629883
| 0.526978
| 7
| 0
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 38
| 111
| 8
| 69
| 24
| 36.59375
| null | null | null | 1
| 139
| null | 92
| 8
| 4,450
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 400
| 0
|
70.68896
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 95,812
| null | null | 40.5
|
white
| 26.199219
| 50
| 0.712891
| 0.625
| 4
| 0
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 13
| 48
| 10.298828
| 175
| 38
| 38.29688
| 260
| 1.899902
| null | 10.898438
| 131
| 7.279297
| 89
| 68
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 13
| 1
|
73.771
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 162,977
| null | null | 58
|
white
| 48.195313
| 107
| 0.074997
| 0.028
| 27
| 0
| 0
|
no
| 0.4
| 0.3
|
dnr after sadm
| 5
| 108
| 11.099609
| 75
| 34
| 39.59375
| 142.5
| 3.199707
| null | 0.899902
| 139
| 7.439453
| 146
| 24
| 3,140
| null | null |
<2 mo. follow-up
| 2.118652
| 5
| 1
|
67.77295
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
$25-$50k
| 0
| 103,944
| null | null | 30.333328
|
white
| 22.796875
| 18
| 0.703979
| 0.61499
| 11
| 0
| 0
|
yes
| 0.8
| 0.75
|
no dnr
| 19
| 71
| 19.398438
| 72
| 36
| 35.79688
| 296.625
| 2.699707
| 0.699951
| 0.799927
| 137
| 7.439453
| 86
| 11
| 900
| null | 0
|
no(M2 and SIP pres)
| 0
| 400
| 0
|
72.97498
|
female
| 0
| 20
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 44
| 59,837
| null | null | 23.666656
|
white
| 25.597656
| 50
| 0.566895
| 0.370972
| 1
| 1
| 0
|
no
| 0.2
| 0.25
|
dnr after sadm
| 3
| 124
| 17.796875
| 69
| 28
| 36
| 447
| null | null | 1.199951
| 136
| 7.509766
| 203
| 19
| 750
| null | 3
|
no(M2 and SIP pres)
| 3
| 399
| 0
|
53.01599
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 44
| 39,559
| null | null | 25
|
black
| 28.5
| 48
| 0.578979
| 0.468994
| 4
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 3
| 65
| 17.296875
| 52
| 29
| 35.5
| 396
| null | 41.59375
| 5.699219
| 143
| 7.189453
| 60
| 80
| 180
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
66.92694
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 11
| null | 0
| 12,287
| null | null | 8
|
white
| 27.898438
| 30
| 0.605957
| 0.28894
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.1
|
no dnr
| 12
| 80
| 4
| 80
| 12
| 37.89844
| null | 4.299805
| 0.599976
| 0.799927
| 137
| null | 93
| 12
| null | 2
| 1
|
<2 mo. follow-up
| 1
| 50
| 1
|
64.05695
|
female
| 1
| 3
|
Coma
|
Coma
| 2
| null | null | 100
| 12,862
| null | null | 22
|
black
| 53.296875
| 89
| 0
| 0
| 1
| 1
| 0
|
no
| 0
| 0
|
no dnr
| 3
| 187
| 8.398438
| 55
| 40
| 38.69531
| 254.28125
| null | null | 0.799927
| 145
| 7.449219
| 123
| 13
| 1,930
| null | null |
<2 mo. follow-up
| 2.657715
| 3
| 1
|
66.30499
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 2
| 2
|
under $11k
| 0
| 8,695
| null | null | 6
|
black
| 24
| 19
| 0.696899
| 0.407959
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 10
| 58
| 12.298828
| 80
| 30
| 39.29688
| 147.5
| null | null | 1.299805
| 144
| 7.269531
| 293
| 34
| 1,800
| 2
| 4
|
no(M2 and SIP pres)
| 4
| 66
| 1
|
77.06
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 61,323
| null | null | 28.5
|
white
| 20.5
| 38
| 0.754883
| 0.612915
| 16
| 1
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 2
| 112
| 9.599609
| 105
| 30
| 37.59375
| 380.9375
| 3.299805
| 1.299805
| 0.5
| 137
| 7.439453
| 78
| 3
| 2,560
| 0
| 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
73.93799
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| 32,261
| null | null | 22.333328
|
white
| 27.296875
| 52
| 0.716919
| 0.629883
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 14
| 58
| 10.398438
| 135
| 22
| 38.29688
| 111.42188
| null | 0.599976
| 0.799927
| 136
| 7.379883
| 170
| 14
| 1,520
| null | 1
| null | 1
| 66
| 1
|
57.60999
|
female
| 1
| 42
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 160,066
| null | null | 28.5
|
black
| 23
| 43
| 0.69397
| 0.602905
| 3
| 1
| 0
|
yes
| 0.95
| 0.9
|
dnr after sadm
| 40
| 73
| 4.799805
| 100
| 36
| 36
| 214.8125
| 3.099609
| 0.399963
| 0.699951
| 125
| 7.419922
| 78
| 7
| 1,310
| null | 1
|
<2 mo. follow-up
| 1
| 42
| 1
|
63.74298
|
male
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 9,053
| null | null | 11.5
|
white
| 30.398438
| 49
| 0.543945
| 0.345947
| 1
| 0
| 0
|
no
| 0.25
| 0.1
|
dnr after sadm
| 3
| 143
| 13
| 75
| 28
| 35.89844
| 280
| 2.5
| 0.599976
| 9.599609
| 131
| 7.379883
| 338
| 58
| 0
| null | 6
|
<2 mo. follow-up
| 6
| 8
| 1
|
68.94196
|
female
| 1
| 5
|
Coma
|
Coma
| 0
| 8
| null | 61
| 19,644
| null | null | 36
|
white
| 20
| 28
| 0.481995
| 0.409973
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 70
| 9.398438
| 80
| 30
| 35
| null | 2.899902
| 1.5
| 1
| 131
| null | 99
| 26
| 1,560
| null | null |
<2 mo. follow-up
| 1.856201
| 5
| 1
|
22.196
|
female
| 1
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
under $11k
| 0
| 323,158
| null | null | 49.5
|
white
| 26.898438
| 63
| 0.853882
| 0.803955
| 10
| 0
| 0
|
no
| 0.4
| 0.4
|
dnr after sadm
| 33
| 83
| 7.599609
| 112
| 20
| 36.39844
| null | null | null | 0.5
| 138
| null | 105
| 5
| null | null | 0
|
<2 mo. follow-up
| 0
| 33
| 1
|
71.98395
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 41
| 94,706
| null | null | 39.5
|
white
| 44.195313
| 89
| 0.051994
| 0.016998
| 8
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 115
| 10.798828
| 125
| 38
| 38.39844
| 160
| 1.699951
| 4.199219
| 6.799805
| 136
| 7.429688
| 181
| 68
| 3,890
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
65.58795
|
male
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 0
| 47,590
| null | null | 23.666656
|
white
| 23
| 25
| 0.716919
| 0.630981
| 1
| 1
| 0
|
yes
| 0.9
| 0.5
|
no dnr
| 17
| 58
| 10.5
| 125
| 36
| 36.79688
| 92.5
| 2.899902
| 1
| 1.599854
| 143
| 7.349609
| 95
| 36
| 2,365
| 0
| 0
| null | 0
| 62
| 1
|
46.18799
|
female
| 0
| 9
|
Coma
|
Coma
| 2
| null | null | 9
| 9,301
| null | null | 9.5
|
black
| 16.796875
| 16
| 0.797974
| 0.757935
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 127
| 13.898438
| 160
| 8
| 36.79688
| 165
| 2
| 1
| 4.699219
| 142
| 7.429688
| 164
| 76
| 4,200
| null | null | null | 2.668945
| 153
| 1
|
75.27997
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 6,089
| null | null | 14
|
white
| 23.898438
| 13
| 0.75293
| 0.608887
| 1
| 0
| 0
|
no
| 0.8
| 0.3
|
dnr before sadm
| 0
| 77
| 12.798828
| 130
| 24
| 37.09375
| 323.75
| null | 0.399963
| 0.5
| 134
| 6.989258
| 97
| 15
| null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 158
| 1
|
59.06897
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 7,544
| null | null | 8.5
|
black
| 15.798828
| 16
| 0.918945
| 0.862915
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 68
| 15.699219
| 115
| 10
| 35.69531
| 174.0625
| null | 2.699707
| 2.899902
| 145
| 7.469727
| 128
| 117
| 2,360
| 0
| null | null | 0.494751
| 391
| 0
|
40.91397
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 9
| 23,896
| null | null | 38
|
white
| 30.699219
| 66
| 0.75293
| 0.67395
| 2
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 3
| 52
| 23.898438
| 145
| 8
| 38.69531
| 200
| 1.5
| 0.599976
| 0.5
| 130
| 7.429688
| 109
| 6
| 2,645
| null | 6
|
<2 mo. follow-up
| 6
| 5
| 1
|
49.41498
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 13
|
$25-$50k
| 0
| 32,612
| null | null | 44
|
white
| 31.398438
| 59
| 0.434998
| 0.315979
| 2
| 0
| 0
|
metastatic
| 0.1
| 0.05
|
dnr after sadm
| 6
| 55
| 16.898438
| 145
| 31
| 38.19531
| 162.5
| 2.799805
| 0.399963
| 1.099854
| 142
| 7.369141
| 117
| 32
| 527
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
33.76297
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 61,906
| null | null | 22.333328
|
white
| 23.796875
| 49
| 0.871948
| 0.827881
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 74
| 1.899902
| 108
| 24
| 37.5
| 227.5
| null | null | 1
| 132
| 7.549805
| 93
| 10
| null | null | null | null | 2.276856
| 389
| 0
|
65.54999
|
male
| 1
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 319,757
| null | null | 34
|
white
| 38.5
| 52
| 0.273987
| 0.165985
| 32
| 0
| 0
|
yes
| 0.1
| 0
|
dnr after sadm
| 37
| 128
| 13.599609
| 125
| 10
| 36.09375
| 556
| 1.199951
| 1.699951
| 0.799927
| 134
| 7.259766
| 214
| 5
| 2,175
| null | null |
<2 mo. follow-up
| 2.163086
| 47
| 1
|
53.15799
|
female
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 108,762
| null | null | 42.666657
|
white
| 32.695313
| 33
| 0.67395
| 0.577881
| 3
| 0
| 0
|
no
| 0.4
| 0.35
|
no dnr
| 20
| 80
| 2.099609
| 60
| 20
| 36.5
| null | 4.299805
| 0.599976
| 1.099854
| 139
| null | 82
| 6
| 3,650
| null | 1
|
<2 mo. follow-up
| 1
| 20
| 1
|
73.39899
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 18
|
$11-$25k
| 0
| 12,499
| null | null | 17
|
white
| 17
| 24
| 0.868896
| 0.782959
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 123
| 7.5
| 128
| 12
| 35.59375
| null | 3.699707
| 1
| 1.799805
| 145
| null | 199
| 36
| 450
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 389
| 0
|
55.13797
|
female
| 1
| 5
|
Coma
|
Coma
| 2
| 14
|
$11-$25k
| 61
| 42,498
| null | null | 31
|
white
| 25.097656
| 23
| 0.402954
| 0.328979
| 5
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 5
| 40
| 12.898438
| 55
| 37
| 39.69531
| 303.3125
| null | 3
| 5.799805
| 136
| 7.379883
| 70
| 67
| 7
| null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
74.935
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 0
| 37,297
| null | null | 18.333328
|
white
| 26.398438
| 33
| 0.711914
| 0.623901
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 109
| 4.099609
| 72
| 18
| 37.69531
| null | 3.699707
| 0.5
| 0.799927
| 136
| null | 92
| 4
| 2,550
| null | 0
|
no(M2 and SIP pres)
| 0
| 388
| 0
|
65.68097
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 44
| 63,760
| null | null | 36.5
|
white
| 19.097656
| 45
| 0.74292
| 0.662964
| 2
| 1
| 0
|
no
| 0.5
| 0.45
|
dnr after sadm
| 13
| 100
| 62
| 100
| 24
| 37.59375
| null | null | 0.399963
| 0.799927
| 142
| null | 94
| 10
| 1,100
| null | 6
|
<2 mo. follow-up
| 6
| 13
| 1
|
66.185
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
| null | 100
| 94,784
| null | null | 56
|
hispanic
| 43.898438
| 71
| 0.002
| 0
| 14
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 75
| 16.796875
| 115
| 30
| 38.29688
| 140
| null | 1.599854
| 1.299805
| 137
| 7.519531
| 181
| 27
| 5,480
| null | null |
<2 mo. follow-up
| 3.267578
| 3
| 1
|
51.14297
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 11,328
| null | null | 11
|
white
| 9.599609
| 3
| 0.909912
| 0.790894
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 140
| 10.298828
| 105
| 26
| 36.29688
| 492
| 3.399902
| null | 8.398438
| 135
| 7.419922
| 282
| 48
| 390
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 386
| 0
|
61.28998
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 40,815
| null | null | 23.5
|
white
| 30.296875
| 54
| 0.717896
| 0.630981
| 1
| 0
| 0
|
no
| 0.5
| 0.1
|
dnr after sadm
| 10
| 142
| 14.699219
| 115
| 33
| 35.69531
| 210
| null | null | 0.599976
| 123
| 7.439453
| 181
| 18
| 1,400
| 0
| 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
33.32199
|
male
| 0
| 61
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 44
| null | null | null | 37
|
black
| 20.898438
| 45
| 0.844971
| 0.790894
| 1
| 1
| 0
|
no
| 0.3
| 0.2
| null | null | 107
| 14.798828
| 60
| 14
| 36.79688
| 306.625
| 2.399902
| 0.699951
| 1.399902
| 142
| 7.40918
| 184
| 36
| 600
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 385
| 0
|
84.66498
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
| null | 37
| 28,875
| null | null | 24.5
|
white
| 34.59375
| 43
| 0.201996
| 0.108994
| 1
| 0
| 0
|
yes
| 0.25
| 0.015625
|
no dnr
| 11
| 142
| 16
| 65
| 30
| 39
| 191.40625
| null | null | 1
| 140
| 7.469727
| 115
| 9
| 3,525
| null | 0
|
no(M2 and SIP pres)
| 0
| 384
| 0
|
62.06198
|
male
| 1
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 251,172
| null | null | 35
|
white
| 27.5
| 40
| 0.612915
| 0.507935
| 24
| 0
| 0
|
yes
| 0.6
| 0.5
|
dnr after sadm
| 30
| 57
| 6.299805
| 60
| 16
| 38
| null | null | 0.599976
| 0.699951
| 133
| null | 120
| 120
| 2,050
| null | 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
47.48297
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 41
| 28,102
| null | null | 47
|
other
| 28
| 38
| 0.68396
| 0.589966
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 4
| 73
| 20.796875
| 125
| 16
| 38.59375
| 570
| null | 1.5
| 0.799927
| 137
| 7.289062
| 288
| 14
| 1,460
| null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
44.79398
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
>$50k
| 9
| 19,115
| null | null | 20
|
white
| 16
| 10
| 0.910889
| 0.878906
| 2
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 5
| 108
| 10.398438
| 140
| 36
| 36.19531
| null | 2.699707
| 1.099854
| 1.5
| 143
| null | 134
| 53
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 384
| 0
|
60.698
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 9
| 52,512
| null | null | 53.5
|
white
| 41.796875
| 70
| 0.115997
| 0.050995
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 102
| 7
| 120
| 24
| 38.69531
| 168.5625
| 2.199707
| null | 1.099854
| 150
| 7.469727
| 98
| 20
| 2,425
| null | 5
|
<2 mo. follow-up
| 5
| 7
| 1
|
75.49597
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 37
| 9,065
| null | null | 7
|
white
| 16.199219
| 29
| 0.78894
| 0.719971
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 7
| 78
| 8.398438
| 80
| 20
| 36.5
| 471.375
| null | 0.899902
| 1.299805
| 134
| 7.459961
| 77
| 23
| 1,850
| null | 5
|
<2 mo. follow-up
| 5
| 14
| 1
|
72.422
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 4
|
$11-$25k
| 41
| 18,527
| null | null | 11.5
|
black
| 21.699219
| 27
| 0.689941
| 0.598999
| 1
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 1
| 117
| 17.097656
| 80
| 20
| 36.69531
| 376
| null | 0.5
| 6
| 139
| 7.369141
| 64
| 53
| 2,450
| null | 1
|
no(M2 and SIP pres)
| 1
| 382
| 0
|
85.01599
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 3,918
| null | null | 4
|
white
| 13.898438
| 10
| 0.834961
| 0.730957
| 1
| 0
| 0
|
yes
| 0.75
| 0.65
|
no dnr
| 4
| 75
| 21.597656
| 125
| 44
| 34.79688
| 212.5
| null | 22.398438
| 0.899902
| 139
| 7.429688
| 76
| 9
| 395
| null | null |
no(M2 and SIP pres)
| 2.355469
| 382
| 0
|
76.00299
|
male
| 0
| 42
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
>$50k
| 0
| 88,879
| null | null | 20.75
|
white
| 24.199219
| 48
| 0.585938
| 0.47699
| 2
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 42
| 75
| 13.798828
| 115
| 38
| 35.39844
| 338.0625
| null | 0.699951
| 0.699951
| 134
| 7.5
| 185
| 22
| 2,410
| 0
| 0
|
<2 mo. follow-up
| 0
| 51
| 1
|
58.24197
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 31,389
| null | null | 29
|
white
| 27.699219
| 33
| 0.806885
| 0.687988
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 9
| 117
| 7.5
| 72
| 20
| 36.79688
| null | 3.899902
| 0.5
| 0.699951
| 136
| null | 168
| 9
| 6,100
| null | null |
no(M2 and SIP pres)
| 2.666016
| 382
| 0
|
64.84094
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 0
| 16
|
$11-$25k
| 0
| 4,582
| null | null | 6
|
white
| 5.399414
| 11
| 0.873901
| 0.715942
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 4
| 65
| 10.398438
| 115
| 29
| 38.59375
| 243.3125
| null | 1
| 1.799805
| 138
| 7.509766
| 117
| 24
| 4,410
| null | 2
|
<2 mo. follow-up
| 2
| 28
| 1
|
45.23199
|
male
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 268,271
| null | null | 39
|
white
| 23.597656
| 51
| 0.850952
| 0.79895
| 3
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 55
| 128
| 12.798828
| 115
| 12
| 36.09375
| 360
| 2.099609
| 0.199982
| 11.898438
| 138
| 7.399414
| 240
| 111
| 600
| null | 0
|
SIP>=30
| 0
| 369
| 1
|
78.836
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 13,603
| null | null | 20
|
black
| 22.796875
| 42
| 0.745972
| 0.598999
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 6
| 112
| 21.296875
| 125
| 40
| 38.39844
| 256
| 2.199707
| 10.599609
| 2.199707
| 132
| 7.459961
| 183
| 28
| 3,040
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 370
| 1
|
67.53497
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 70,783
| null | null | 27.333328
|
black
| 38.195313
| 44
| 0.442993
| 0.323975
| 3
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 21
| 95
| 27.796875
| 125
| 38
| 37.59375
| 263.3125
| 4.199219
| null | 1
| 140
| 7.459961
| 192
| 28
| 1,065
| null | 0
|
no(M2 and SIP pres)
| 0
| 381
| 0
|
34.75699
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 44
| 51,410
| null | null | 23.333328
|
black
| 18.398438
| 26
| 0.856934
| 0.807983
| 2
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 17
| 58
| 13.199219
| 118
| 50
| 38.39844
| 206.65625
| null | 1.599854
| 1.199951
| 135
| 7.449219
| 351
| 37
| 3,605
| null | 0
|
no(M2 and SIP pres)
| 0
| 380
| 0
|
71.20599
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,433
| null | null | 10
|
white
| 15.199219
| 18
| 0.855957
| 0.761963
| 1
| 0
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 6
| 58
| 10.199219
| 65
| 10
| 36.89844
| 190
| null | null | 2.599609
| 132
| 7.399414
| 160
| 81
| 4,690
| 0
| 5
|
no(M2 and SIP pres)
| 5
| 379
| 0
|
69.78796
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 35,607
| null | null | 10
|
black
| 16.699219
| 10
| 0.846924
| 0.793945
| 7
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 49
| 20.597656
| 200
| 12
| 37.69531
| 140
| 3
| 13.5
| 4.099609
| 151
| 7.279297
| 41
| 68
| 0
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 379
| 0
|
51.33499
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
under $11k
| 0
| 65,095
| null | null | 26.333328
|
white
| 26.5
| 37
| 0.773926
| 0.700928
| 1
| 0
| 0
|
yes
| 0.9
| 0.85
|
no dnr
| 17
| 68
| 11.798828
| 55
| 11
| 38.89844
| 165
| null | null | 0.699951
| 135
| 7.439453
| 149
| 17
| 3,270
| null | 0
|
no(M2 and SIP pres)
| 0
| 365
| 0
|
72.08197
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
$11-$25k
| 0
| 2,941
| null | null | 8
|
white
| 16.796875
| 7
| 0.865967
| 0.777954
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 4
| 68
| 12.298828
| 125
| 36
| 36.39844
| 186.65625
| 3.399902
| 0.599976
| 1.099854
| 138
| 7.419922
| 331
| 24
| 565
| 3
| 0
|
no(M2 and SIP pres)
| 0
| 363
| 0
|
79.38397
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 2
|
under $11k
| 0
| 17,612
| null | null | 48
|
black
| 42
| 71
| 0.186981
| 0.097992
| 1
| 0
| 0
|
yes
| 0.1
| 0.1
|
dnr after sadm
| 2
| 138
| 16.597656
| 195
| 35
| 41.09375
| 296.375
| null | null | 0.899902
| 131
| 7.449219
| 181
| 11
| 1,587
| null | 5
|
<2 mo. follow-up
| 5
| 4
| 1
|
73.71698
|
male
| 1
| 12
|
Lung Cancer
|
Cancer
| 2
| 11
|
$11-$25k
| 0
| 41,184
| null | null | 11.5
|
white
| 19.398438
| 2
| 0.633911
| 0.322998
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 4
| 107
| 5.299805
| 80
| 20
| 36.69531
| null | 2.699707
| 1.5
| 2.299805
| 144
| null | 89
| 32
| 675
| null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
73.81494
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 10,558
| null | null | 12
|
white
| 10.5
| 12
| 0.800903
| 0.576904
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 3
| 28
| 12
| 0
| 0
| 38.39844
| 306.625
| 3.899902
| null | 11.798828
| 153
| 7.40918
| 192
| 87
| 0
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 362
| 0
|
48.39999
|
female
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 91,974
| null | null | 19
|
white
| 32
| 73
| 0.711914
| 0.623901
| 3
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 43
| 111
| 19.5
| 124
| 22
| 36.29688
| null | null | null | 0.599976
| 143
| null | 236
| 15
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 361
| 0
|
80.29297
|
male
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$25-$50k
| 0
| 147,291
| null | null | 28.25
|
white
| 32.5
| 75
| 0.56189
| 0.449951
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 34
| 65
| 7.599609
| 75
| 23
| 37.79688
| 203.3125
| null | null | 3
| 135
| 7.509766
| 131
| 112
| 4,060
| null | 0
|
<2 mo. follow-up
| 0
| 34
| 1
|
86.55194
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 8,949
| null | null | 11
|
black
| 24.597656
| 33
| 0.710938
| 0.622925
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 6
| 62
| 8.199219
| 120
| 42
| 36.79688
| 157.5
| 2.299805
| 1.399902
| 0.699951
| 150
| 7.469727
| 112
| 33
| 1,730
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 360
| 0
|
37.57999
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 52,072
| null | null | 24
|
white
| 23.199219
| 34
| 0.887939
| 0.848999
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 15
| 65
| 28.898438
| 125
| 9
| 36.79688
| 205
| 2
| null | 1.299805
| 144
| 7.229492
| 104
| 31
| 1,165
| null | 0
| null | 0
| 360
| 0
|
56.38098
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
under $11k
| 9
| 123,004
| null | null | 32.25
|
white
| 23.5
| 50
| 0.807983
| 0.743896
| 2
| 1
| 0
|
no
| 0.65
| 0.6
|
no dnr
| 37
| 73
| 12.5
| 148
| 24
| 36.19531
| null | 2.599609
| 6.099609
| 0.899902
| 129
| null | 172
| 31
| 465
| null | 6
|
no(M2 and SIP pres)
| 6
| 359
| 0
|
69.47595
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 55
| 74,091
| null | null | 29.333328
|
black
| 22.398438
| 43
| 0.574951
| 0.463989
| 5
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 17
| 132
| 8.699219
| 105
| 13
| 38.59375
| 230
| null | null | 0.5
| 137
| 7.539062
| 180
| 7
| 2,945
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 358
| 0
|
61.79599
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 41
| 66,966
| null | null | 36
|
white
| 33.296875
| 55
| 0.373962
| 0.255981
| 1
| 0
| 0
|
yes
| 0.4
| 0.4
|
no dnr
| 15
| 108
| 46.59375
| 140
| 12
| 38
| 356
| 1.199951
| 3
| 1.599854
| 130
| 7.299805
| 140
| 39
| 1,385
| null | 5
|
<2 mo. follow-up
| 5
| 15
| 1
|
75.92297
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 0
| 89,086
| null | null | 34.666657
|
white
| 25.796875
| 40
| 0.718994
| 0.632935
| 2
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 20
| 48
| 17.796875
| 170
| 33
| 38.59375
| 128
| null | null | 5
| 131
| 7.369141
| 110
| 111
| 235
| null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
83.23297
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 41
| 16,502
| null | null | 29
|
white
| 74.5
| 64
| 0
| 0
| 5
| 0
| 1
|
yes
| 0
| 0
|
dnr after sadm
| 2
| 80
| 32.898438
| 70
| 6
| 39.39844
| 150
| 2.599609
| 0.899902
| 1.099854
| 131
| 7.479492
| 104
| 30
| 5,145
| null | 4
|
<2 mo. follow-up
| 4
| 3
| 1
|
71.31598
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 26
| 28,355
| null | null | 21.5
|
white
| 33
| 64
| 0.16098
| 0.079987
| 7
| 0
| 0
|
metastatic
| 0.1
| 0
|
dnr after sadm
| 2
| 107
| 9.5
| 72
| 24
| 36.39844
| null | 3.799805
| 0.399963
| 0.5
| 141
| null | 210
| 3
| 1,975
| null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
59.59198
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 83,944
| null | null | 19.666656
|
white
| 16
| 10
| 0.846924
| 0.794922
| 8
| 0
| 0
|
yes
| null | null |
no dnr
| 20
| 77
| 16.398438
| 66
| 22
| 36.19531
| 150
| null | null | 0.799927
| 133
| 7.449219
| 82
| 17
| 2,650
| null | null | null | 2.461426
| 355
| 0
|
42.49698
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 44
| 76,321
| null | null | 28
|
white
| 25.199219
| 30
| 0.75
| 0.670898
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 23
| 80
| 18.398438
| 80
| 20
| 36.59375
| 314.25
| null | null | 1.199951
| 141
| 7.379883
| 109
| 33
| 1,925
| null | 0
|
no(M2 and SIP pres)
| 0
| 355
| 0
|
49.78
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 9
| 22,099
| null | null | 21.5
|
white
| 29.699219
| 27
| 0.578979
| 0.257996
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 9
| 58
| 11.099609
| 115
| 26
| 35.29688
| 224
| null | null | 1.5
| 130
| 7.129883
| 290
| 110
| 990
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 355
| 0
|
66.11395
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$25-$50k
| 0
| 38,449
| null | null | 22
|
white
| 23.699219
| 26
| 0.793945
| 0.725952
| 2
| 0
| 0
|
no
| 0.9
| 0.88
|
no dnr
| 10
| 65
| 21.796875
| 125
| 22
| 36
| 148.875
| 2.399902
| 0.299988
| 2.399902
| 138
| 7.299805
| 195
| 89
| 950
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 353
| 0
|
75.21997
|
male
| 1
| 8
|
Lung Cancer
|
Cancer
| 1
| 3
|
under $11k
| 9
| 17,272
| null | null | 33.5
|
black
| 21.597656
| 18
| 0.533936
| 0.210999
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 8
| 108
| 6.899414
| 115
| 32
| 38.5
| 304
| 1.799805
| null | 6.799805
| 142
| 7.379883
| 96
| 72
| 2,225
| 0
| null |
<2 mo. follow-up
| 0.494751
| 8
| 1
|
75.61395
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 14,778
| null | null | 12
|
black
| 23.199219
| 38
| 0.783936
| 0.653931
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 7
| 85
| 19.898438
| 135
| 31
| 36.19531
| 132
| null | 4.899414
| 1.599854
| 130
| 7.359375
| 149
| 51
| 1,210
| null | null | null | 2.270996
| 354
| 0
|
87.71497
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 8,642
| null | null | 14
|
black
| 19.398438
| 28
| 0.790894
| 0.66394
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 45
| 13.199219
| 135
| 28
| 38.09375
| 220
| null | null | 0.899902
| 133
| 7.40918
| 144
| 11
| 3,160
| null | null | null | 3.406738
| 340
| 1
|
65.008
|
male
| 0
| 18
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 15,592
| null | null | 6.333332
|
white
| 16
| 17
| 0.726929
| 0.453979
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 18
| 68
| null | 78
| 26
| 36.59375
| null | null | null | 1.399902
| 134
| null | 97
| 30
| 2,590
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 352
| 0
|
70.44495
|
male
| 1
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 3
|
under $11k
| 44
| 171,822
| null | null | 33.75
|
white
| 21.097656
| 10
| 0.658936
| 0.560913
| 4
| 0
| 0
|
no
| 0.05
| 0.5
|
dnr after sadm
| 38
| 107
| 13.398438
| 65
| 25
| 35
| 276.625
| null | null | 0.599976
| 132
| 7.459961
| 170
| 13
| 1,550
| null | 0
|
<2 mo. follow-up
| 0
| 39
| 1
|
76.23499
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 26
| 30,143
| null | null | 21
|
white
| 23.296875
| 17
| 0.67395
| 0.577881
| 2
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 13
| 118
| 10.898438
| 55
| 12
| 35.89844
| 190
| null | 1.599854
| 1.599854
| 136
| 7.399414
| 154
| 29
| 7,560
| null | 1
|
no(M2 and SIP pres)
| 1
| 351
| 0
|
37.689
|
female
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 61,762
| null | null | 38
|
white
| 33.296875
| 70
| 0.358948
| 0.241974
| 13
| 0
| 0
|
yes
| 0.5
| 0.2
|
no dnr
| 8
| 68
| 12.898438
| 110
| 9
| 38.5
| 217.125
| null | null | 1.199951
| 142
| 7.329102
| 325
| 48
| 1,460
| 0
| null |
<2 mo. follow-up
| 0.494751
| 8
| 1
|
71.22198
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| 109,881
| null | null | 40
|
white
| 25.5
| 49
| 0.694946
| 0.603882
| 10
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 13
| 42
| 18.699219
| 125
| 8
| 39.89844
| 166
| null | null | 3.699707
| 143
| 7.259766
| 122
| 77
| 15
| null | 0
|
<2 mo. follow-up
| 0
| 13
| 1
|
58.66699
|
male
| 0
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 130,457
| null | null | 23.75
|
white
| 19.5
| 11
| 0.845947
| 0.792969
| 1
| 0
| 0
|
yes
| 0.7
| 0.6
|
dnr after sadm
| 13
| 95
| 6.799805
| 68
| 20
| 37
| null | 3.899902
| 1
| 0.899902
| 138
| null | 98
| 6
| 5,060
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 196
| 1
|
56.91199
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 13,279
| null | null | 10.5
|
white
| 21.699219
| 36
| 0.866943
| 0.779907
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 12
| 72
| 29.097656
| 125
| 28
| 36.29688
| 192.5
| 2.5
| 3.5
| 1.699951
| 138
| 7.449219
| 123
| 74
| 1,645
| 6
| null |
no(M2 and SIP pres)
| 4.527344
| 82
| 1
|
33.59598
|
female
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 82,387
| null | null | 25.333328
|
white
| 34.898438
| 49
| 0.262939
| 0.156982
| 6
| 0
| 0
|
metastatic
| null | null |
no dnr
| 18
| 60
| 14.798828
| 60
| 10
| 38.19531
| 283.3125
| 2.599609
| 1.299805
| 9.099609
| 134
| 7.379883
| 249
| 39
| 0
| null | 0
|
no(M2 and SIP pres)
| 0
| 348
| 0
|
66.82495
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 8,769
| null | null | 6
|
white
| 16.699219
| 13
| 0.710938
| 0.428955
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 70
| 3
| 125
| 28
| 36.29688
| 125
| 2.699707
| null | 1.099854
| 132
| 7.539062
| 140
| 42
| 3,500
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 348
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.